Comparative analysis of TCGA and CGGA693 cohorts revealed significant differences in multiple clinical characteristics between LRGs-high and -low glioma patient groups—including age, WHO grade, IDH status, and 1p/19q co-deletion—but showed no association with gender distribution (Figures 4A, B). The gene discussed is IDH1; the disease is glioma.